| Literature DB >> 26751140 |
T Havrdova1, P Boucek1, F Saudek1, L Voska1, A Lodererova1, N Üçeyler2, H Vondrova3, J Skibova1, K Lipar1, C Sommer2.
Abstract
Whether nerve fiber loss, a prominent feature of advanced diabetic neuropathy, can be reversed by reestablishment of normal glucose control remains questionable. We present 8-year follow-up data on epidermal nerve fiber (ENF) density and neurological function in patients with type 1 diabetes after simultaneous pancreas and kidney transplantation (SPK) with long-term normoglycemia. Distal thigh skin biopsies with ENF counts, vibration perception thresholds (VPTs), autonomic function testing (AFT) and electrophysiological examinations were performed at time of SPK and 2.5 and 8 years after SPK in 12 patients with type 1 diabetes. In comparison to controls, baseline ENF density, VPT and AFT results of patients indicated severe neuropathy. At follow-up, all SPK recipients were insulin independent with excellent glycemic control and kidney graft function; however, the severe ENF depletion present at baseline had not improved, with total ENF absence in 11 patients at 8-year follow-up. Similarly, no amelioration occurred in the VPT and AFT results. Numerical improvement was seen in some electrophysiological parameters; however, statistical significance was achieved only in median motor nerve conduction velocity. ENF loss and functional deficits in advanced diabetic peripheral neuropathy are rarely reversible, even by long-term normoglycemia, which underscores the importance of neuropathy prevention by early optimal glycemic control. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: clinical research/practice; diabetes: secondary complications; diabetes: type 1; endocrinology/diabetology; neurology; pancreas/simultaneous pancreas-kidney transplantation
Mesh:
Year: 2016 PMID: 26751140 DOI: 10.1111/ajt.13715
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086